Jobb och karriärInvesterareCOVID-19
  1. Hem
  2. Bilddiagnostik
  3. Computed Tomography
  4. The NAEOTOM Alpha class
  5. NAEOTOM Alpha
  6. Oncology imaging with the NAEOTOM Alpha class
Key Visual Siemens Healthineers Quantum Technology showing the face of a middle-aged women, next to the abstract visualization of a photon-counting detector with its precise pulses and the clinical image of an abdomen in the center of the pulses.

Oncology imaging with the NAEOTOM Alpha classTurn each scan into accurate decisions


Offering diagnostic image consistency for true precision

In oncology, accurate and precise imaging plays a pivotal role in diagnosis, treatment planning, and monitoring the effectiveness of therapies. The NAEOTOM® Alpha class with its groundbreaking Quantum Technology offers a new dimension of accuracy and clarity in oncology imaging. It delivers high image quality, empowering healthcare professionals with the ability to detect, characterize, and monitor tumors with precision.

Whether in high-resolution imaging, high-contrast and low-dose imaging, or spectral imaging, Quantum Technology enables consistent and precise staging and monitoring across the board without any compromises. All relevant CT results can be gained from just a single scan.

Take clinical decision-making to a whole new level by leveraging the visualization of oncologic features such as tumors and tumor-feeding vessels.

Moving beyond limitations

How to best combine spatial resolution, acquisition speed, and spectral information in one scan? Professor Claudia Lengerke, head of the department of hematology/oncology at University Hospital Tubingen, Germany, and Professor Konstantin Nikolaou, diagnostic and interventional radiology department chair, found the answer with NAEOTOM Alpha.

NAEOTOM Alpha.Prime, NAEOTOM Alpha.Pro and NAEOTOM Alpha.Peak are pending 510(k) clearance and are not yet commercially available in the United States and other regions.

1/12
Spectral information10
Consistency & quantification02
Clinical image combining spectral information with high resolution to assess pancreatic insulinoma with high precision.

Spectral information is combined with high resolution to assess pancreatic insulinoma with high precision compared to conventional CT and MRI.
Courtesy of Daniele Marin, MD, Duke University, North Carolina, USA

Clinical image combining spectral information with high resolution to assess pancreatic insulinoma with high precision.
Clinical image of a kidney applying inherently available spectral information for the evaluation of challenging lesions.
Clinical image of a kidney applying inherently available spectral information for the evaluation of challenging lesions.
Clinical images of early-stage liver metastasis.
Spectral imaging of pancreatic neuroendocrine tumors, MPR, cVRT and iodine maps.
Clinical images, MPR, VNC, iodine maps: inherently available spectral information for incidental lesion evaluation.
Whole-body scan and liver staging with outstanding sub-millimeter image quality at low dose for oncology assessment.
Low dose image of functional liver lesion assessment with high sub-millimeter image quality.
Whole-body scan, MPR and cVRT: spectral information and low dose for oncology assessment.
Whole-body low-dose image with high detection capability for multiple myeloma with photon-counting CT.
Abdomen image of an obese patient, acquired with NAEOTOM Alpha, combining high image-quality, speed, and spectral information.
Functional assessment of liver fat as a predictor of liver pathologies.
1/12

 

The right image quality and spectral information for more patients1

Quantum Spectral Imaging redefines consistency by providing monoenergetic images as the standard image type for every scan. Perform numerical measurements that are independent from the selected scan parameters – and build your clinical decisions on standardized results throughout the patient journey. See for yourself.

Clinical cVRT image of a multi-phasic CME abdomen CT after liver transplantation.
Courtesy of Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

Relevant results in one go

With Quantum Technology, the dilemma of having to decide before a scan which information is most relevant is a thing of the past. It redefines clinical decision-making by providing all relevant CT results with one single scan – in Quantum HD image quality and without compromising on spectral information or scan speed.

Apply these benefits to detect small liver lesions or pancreatic tumors, take advantage of the potential of virtual-non contrast imaging, evaluate multiple myeloma, or clearly see tumor-feeding vessels.

Clinical image of an abdomen acquired with low dose and contrast media.
Courtesy of Dr. Jones & Partners, SAHMRI, Adelaide, Australia

Low dose and contrast media

Quantum Technology is designed to consistently acquire high quality images while optimizing radiation exposure for patients. Compared to conventional CT scanners, the radiation dose can be lowered. This particularly benefits oncology patients who require frequent imaging for treatment monitoring and follow-ups.

The same applies for contrast media usage, where increased contrast-to-noise ratio and inherent low keV imaging capabilities has the potential to enable a reduction of contrast media dose for sensitive patient groups.

Clinical image of a kidney applying inherently available spectral information for the evaluation of challenging lesions.
Courtesy of Charles University Hospital, Pilsen, Czech Republic

Consistent scans with monoenergetic images

Quantum Technology redefines diagnostic consistency by providing monoenergetic images as the standard image type for every scan. Perform numerical measurements independent of scan parameters – and derive clinical decisions from standardized results throughout the patient journey.

Comparability across several acquisitions allows users to confidently determine whether changes between scans are a result of therapy or physiology of the lesion, and not driven by inconsistencies in imaging parameters.

Applying NAEOTOM Alpha and its photon-counting technology in oncologic imaging, we can now combine the required spatial resolution, the acquisition speed, and the spectral information in the same scan in practically all patients.3
Konstantin Nikolaou, MD, PhD
Konstantin Nikolaou, MD, PhD
Diagnostic and Interventional Radiology chair,
University Hospital Tubingen, Tubingen, Germany

Scientifically proven technology

Discover the full potential of the NAEOTOM Alpha class.

The NAEOTOM Alpha class in other clinical fields

 

NAEOTOM Alpha.Prime, NAEOTOM Alpha.Pro and NAEOTOM Alpha.Peak are pending 510(k) clearance, and are not yet commercially available in the United States and other regions. 
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
Spectral analysis functionality subject to local availability.
1
Max. table load is 307 kg/677 lbs.
2
Liver Fat Quantification is currently under development; it is not for sale and its future availability cannot be guaranteed.
3
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customers’ unique setting. Because there is no “typical” hospital and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.